Zimmer Biomet Holdings Cash on Hand 2010-2025 | ZBH
Zimmer Biomet Holdings cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Zimmer Biomet Holdings cash on hand for the quarter ending March 31, 2025 was $1.385B, a 252.29% increase year-over-year.
- Zimmer Biomet Holdings cash on hand for 2024 was $0.526B, a 26.38% increase from 2023.
- Zimmer Biomet Holdings cash on hand for 2023 was $0.416B, a 10.67% increase from 2022.
- Zimmer Biomet Holdings cash on hand for 2022 was $0.376B, a 0.63% decline from 2021.
| Zimmer Biomet Holdings Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $526 |
| 2023 | $416 |
| 2022 | $376 |
| 2021 | $378 |
| 2020 | $802 |
| 2019 | $618 |
| 2018 | $543 |
| 2017 | $524 |
| 2016 | $634 |
| 2015 | $1,624 |
| 2014 | $1,696 |
| 2013 | $1,808 |
| 2012 | $1,556 |
| 2011 | $1,224 |
| 2010 | $934 |
| 2009 | $758 |
| Zimmer Biomet Holdings Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,385 |
| 2024-12-31 | $526 |
| 2024-09-30 | $569 |
| 2024-06-30 | $420 |
| 2024-03-31 | $393 |
| 2023-12-31 | $416 |
| 2023-09-30 | $292 |
| 2023-06-30 | $320 |
| 2023-03-31 | $330 |
| 2022-12-31 | $376 |
| 2022-09-30 | $545 |
| 2022-06-30 | $386 |
| 2022-03-31 | $436 |
| 2021-12-31 | $378 |
| 2021-09-30 | $920 |
| 2021-06-30 | $1,042 |
| 2021-03-31 | $724 |
| 2020-12-31 | $802 |
| 2020-09-30 | $967 |
| 2020-06-30 | $713 |
| 2020-03-31 | $2,434 |
| 2019-12-31 | $618 |
| 2019-09-30 | $513 |
| 2019-06-30 | $403 |
| 2019-03-31 | $587 |
| 2018-12-31 | $543 |
| 2018-09-30 | $525 |
| 2018-06-30 | $481 |
| 2018-03-31 | $1,765 |
| 2017-12-31 | $524 |
| 2017-09-30 | $481 |
| 2017-06-30 | $450 |
| 2017-03-31 | $1,040 |
| 2016-12-31 | $634 |
| 2016-09-30 | $489 |
| 2016-06-30 | $976 |
| 2016-03-31 | $1,010 |
| 2015-12-31 | $1,624 |
| 2015-09-30 | $1,810 |
| 2015-06-30 | $1,884 |
| 2015-03-31 | $9,282 |
| 2014-12-31 | $1,696 |
| 2014-09-30 | $1,747 |
| 2014-06-30 | $1,698 |
| 2014-03-31 | $1,588 |
| 2013-12-31 | $1,808 |
| 2013-09-30 | $1,506 |
| 2013-06-30 | $1,236 |
| 2013-03-31 | $1,201 |
| 2012-12-31 | $1,556 |
| 2012-09-30 | $1,489 |
| 2012-06-30 | $1,336 |
| 2012-03-31 | $1,229 |
| 2011-12-31 | $1,224 |
| 2011-09-30 | $978 |
| 2011-06-30 | $946 |
| 2011-03-31 | $866 |
| 2010-12-31 | $934 |
| 2010-09-30 | $982 |
| 2010-06-30 | $987 |
| 2010-03-31 | $871 |
| 2009-12-31 | $758 |
| 2009-09-30 | $443 |
| 2009-06-30 | $280 |
| 2009-03-31 | $216 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.095B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.329B | 27.82 |
| Boston Scientific (BSX) | United States | $151.540B | 37.94 |
| Stryker (SYK) | United States | $146.015B | 30.53 |
| EssilorLuxottica (ESLOY) | France | $127.709B | 0.00 |
| Medtronic (MDT) | Ireland | $109.786B | 15.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.554B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.214B | 28.03 |
| ResMed (RMD) | United States | $36.648B | 27.53 |
| Agilent Technologies (A) | United States | $32.650B | 21.28 |
| GE HealthCare Technologies (GEHC) | United States | $32.569B | 15.46 |
| Terumo (TRUMY) | Japan | $26.857B | 34.88 |
| Insulet (PODD) | United States | $22.464B | 88.18 |
| Koninklijke Philips (PHG) | Netherlands | $21.600B | 15.53 |
| Baxter (BAX) | United States | $15.380B | 11.48 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.819B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.043B | 21.03 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 13.90 |
| Prestige Consumer Healthcare (PBH) | United States | $4.190B | 18.72 |
| Perrigo (PRGO) | Ireland | $3.610B | 9.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.346B | 15.24 |
| ICU Medical (ICUI) | United States | $3.233B | 23.84 |
| Envista Holdings (NVST) | United States | $3.178B | 26.41 |
| GN Store Nord (GNNDY) | Denmark | $2.155B | 17.85 |
| QuidelOrtho (QDEL) | United States | $2.102B | 14.46 |
| LeMaitre Vascular (LMAT) | United States | $1.865B | 41.69 |
| AtriCure (ATRC) | United States | $1.729B | 0.00 |
| Acuren (TIC) | United States | $1.228B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.196B | 12.14 |
| Green Thumb Industries (GTBIF) | United States | $1.101B | 24.76 |
| Neogen (NEOG) | United States | $1.077B | 13.78 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.016B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.972B | 12.42 |
| InMode (INMD) | Israel | $0.931B | 9.38 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.619B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.571B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.564B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.523B | 0.00 |
| Owens & Minor (OMI) | United States | $0.515B | 4.27 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.412B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.340B | 12.52 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.313B | 55.70 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Sanara MedTech (SMTI) | United States | $0.260B | 0.00 |
| ZimVie (ZIMV) | United States | $0.255B | 11.61 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.231B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.217B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.205B | 0.00 |
| Brainsway (BWAY) | Israel | $0.198B | 52.30 |
| Omeros (OMER) | United States | $0.196B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.195B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.45 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.80 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Vireo Growth (VREOF) | United States | $0.125B | 0.00 |
| Jin Medical (ZJYL) | China | $0.121B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.56 |
| TerrAscend (TSNDF) | Canada | $0.089B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Nephros (NEPH) | United States | $0.035B | 47.43 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |